Sonnenblick A - Search Results

1

p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.

Sonnenblick A, Salgado R, Brohée S, Zahavi T, Peretz T, Van den Eynden G, Rouas G, Salmon A, Francis PA, Di Leo A, Crown JPA, Viale G, Daly L, Javdan B, Fujisawa S, De Azambuja E, Lieveke A, Piccart MJ, Bromberg JF, Sotiriou C. Sonnenblick A, et al. Int J Oncol. 2018 Feb;52(2):424-432. doi: 10.3892/ijo.2017.4212. Epub 2017 Nov 27. Int J Oncol. 2018. PMID: 29207087 Free PMC article. Clinical Trial.

2

Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.

Sonnenblick A, Meirovitz A. Sonnenblick A, et al. Int J Clin Oncol. 2010 Aug;15(4):420-2. doi: 10.1007/s10147-010-0050-0. Epub 2010 Mar 10. Int J Clin Oncol. 2010. PMID: 20217448 Review.

3

Liver failure on the background of pseudocirrhosis in patients with liver metastasis from breast cancer, who responded to treatment.

Sonnenblick A, Appelbaum L, Peretz T. Sonnenblick A, et al. Onkologie. 2011;34(4):199-201. doi: 10.1159/000327010. Epub 2011 Mar 23. Onkologie. 2011. PMID: 21447980 No abstract available.

4

Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy.

Sonnenblick A, Kadouri L, Appelbaum L, Peretz T, Sagi M, Goldberg Y, Hubert A. Sonnenblick A, et al. Cancer Biol Ther. 2011 Aug 1;12(3):165-8. doi: 10.4161/cbt.12.3.16292. Epub 2011 Aug 1. Cancer Biol Ther. 2011. PMID: 21613821

5

Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis.

Sonnenblick A, Shriki A, Galun E, Axelrod JH, Daum H, Rottenberg Y, Hamburger T, Mali B, Peretz T. Sonnenblick A, et al. Clin Transl Oncol. 2012 Mar;14(3):232-6. doi: 10.1007/s12094-012-0789-z. Clin Transl Oncol. 2012. PMID: 22374428

6

[Update: adjuvant trastuzumab in HER2 positive breast cancer].

Tahover E, Sonnenblick A, Peretz T, Katz D. Tahover E, et al. Among authors: sonnenblick a. Harefuah. 2012 Jan;151(1):37-42, 61. Harefuah. 2012. PMID: 22670500 Review. Hebrew.

7

Long-term outcome of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected gastric cancer.

Sonnenblick A, Rottenberg Y, Kadouri L, Wygoda M, Rivkind A, Vainer GW, Peretz T, Hubert A. Sonnenblick A, et al. Med Oncol. 2012 Dec;29(5):3035-8. doi: 10.1007/s12032-012-0302-0. Epub 2012 Jul 8. Med Oncol. 2012. PMID: 22773040 Clinical Trial.

8

Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer.

Sonnenblick A, Uziely B, Nechushtan H, Kadouri L, Galun E, Axelrod JH, Katz D, Daum H, Hamburger T, Maly B, Allweis TM, Peretz T. Sonnenblick A, et al. Breast Cancer Res Treat. 2013 Apr;138(2):407-13. doi: 10.1007/s10549-013-2453-x. Epub 2013 Feb 28. Breast Cancer Res Treat. 2013. PMID: 23446809

9

Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?

Sonnenblick A, Fumagalli D, Sotiriou C, Piccart M. Sonnenblick A, et al. Cancer Treat Rev. 2014 Oct;40(9):1089-95. doi: 10.1016/j.ctrv.2014.07.005. Epub 2014 Aug 12. Cancer Treat Rev. 2014. PMID: 25151406 Review.

10

An update on PARP inhibitors--moving to the adjuvant setting.

Sonnenblick A, de Azambuja E, Azim HA Jr, Piccart M. Sonnenblick A, et al. Nat Rev Clin Oncol. 2015 Jan;12(1):27-41. doi: 10.1038/nrclinonc.2014.163. Epub 2014 Oct 7. Nat Rev Clin Oncol. 2015. PMID: 25286972 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page